2-HYDROXY-6-((2-(2-(2-HYDROXY-1-METHYL-ETHYL)PYRAZOL-3-YL)-3-PYRIDYL)METHOXY)BENZALDEHYDE
UNII C0G4Y3D3N0
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-hydroxy-6-((2-(2-(2-hydroxy-1-methyl-ethyl)pyrazol-3-yl)-3-pyridyl)methoxy)benzaldehyde, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C0G4Y3D3N0.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H19N3O4 AYEWYTMVRXAVBA-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-hydroxy-6-((2-(2-(2-hydroxy-1-methyl-ethyl)pyrazol-3-yl)-3-pyridyl)methoxy)benzaldehyde. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.